PSP risk is linked to the H1B tau gene haplotype and can be explained by one SNP, htSNP167, which creates a TFCP2 binding site in the regulatory region of this gene [45]. This evidence concerns the gene TFCP2 and supranuclear palsy, progressive, 1.